Farmas USA

Nvax

Como no me gusta AMRN (ya le saque algunos cuartos), voy a dejar lo que tengo a 7'70 de media y voy a jugar también, que sube cash, que baja a esperar que ya subirá.

NVAX

Vaya cierre más cojonudo, así da gusto encarar el fin de semana:)))

Supongo que el mercado esperara cierta correccion del Brent tras el +9% de hoy ... Y espero que no se lo tome a mal sino como algo normal ... No vayamos a tener el Lunes la contrapartida negativa de hoy ....

Amén, framus :))

Hasta en semanal hemos ganado a papá...nvax 1.69%...IBB 1.35%

THLD ha recibido ya la cartita de la SEC, lleva 30 dias por debajo de 1$ ...

http://investor.thresholdpharm.com/secfiling.cfm?filingid=1144204-16-76687&CIK=1183765

On January 21, 2016, Threshold Pharmaceuticals, Inc. (the “Company”) received a notice from the from the staff (the “Staff”) of The NASDAQ Stock Market LLC (“Nasdaq”) that, for the previous 30 consecutive business days, the closing bid price for the Company’s common stock was below the $1.00 per share minimum bid price requirement for continued listing on The NASDAQ Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company will have 180 calendar days, or until July 19, 2016, to regain compliance with the Bid Price Rule. To regain compliance with the Bid Price Rule, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of 10 consecutive business days at any time during this 180-day period. If the Company regains compliance with the Bid Price Rule, Nasdaq will provide the Company with written confirmation and will close the matter.

If the Company does not regain compliance with the rule by July 19, 2016, the Company may be eligible for an additional 180 calendar day compliance period. To qualify, the Company would need to meet, on the 180th day of the first compliance period, the continued listing requirement for market value of publicly held shares and all other applicable standards for initial listing on The NASDAQ Capital Market, with the exception of the bid price requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is not eligible for a second compliance period, Nasdaq will notify the Company that its common stock will be subject to delisting. In the event of such a notification, the Company may appeal the Staff’s determination to delist its securities, but there can be no assurance the Staff would grant the Company’s request for continued listing.

THLD

Anda que no queda terreno por recuperar. Eso si, el gap d noviembre 2014 en 270 ya es historia.

IBB DIARIO

IBB SEMANAL

Bonita vela semanal ...

Y los que le quedan
Thld

THLD

Por lo que llevo visto en farmas, cuando ya está por la mitad de abajo del dólar y empiezar las cartitas, el reverse suele ser casi inevitable salvo excepciones. Queda fuera de mi lista de seguimiento.

No ha acabado mal la semana al final ¿eh?, las Novax subiendo, y las Nymox otra vez por encima de mi precio.